NR4A1 and neoplasm: Previous studies using mouse MC-38 cells show that in a syngeneic immunocompetent mouse model using this cell line as xenograft results in tumor growth and also splenomegaly and thus the effects of CDIM/NR4A1 antagonists in the spleen can also be investigated [32–35].